In the next 10 years, 150+ drugs will come off patent protection. These drugs are worth over $100B in sales.
Our Mission
Laxxon Medical is dedicated to engineering patented 3D pharmaceutical solutions which optimize products and benefit patients.
The basis of Laxxon's pharmaceutical solutions is our cutting-edge 3D screen printing technology and the extensive intellectual property surrounding it.
Our commitment to innovation and health is fueled by the expertise, integrity, agility, and diversity of the Laxxon team.
Laxxon strives to accelerate pharmaceutical progress globally by establishing ourselves as the leader in the field of 3D printed drugs.
Newsroom
Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Newsroom
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP facilities in Italy and US.
Laxxon is dedicated to revolutionizing the pharmaceutical industry with better, smarter drug delivery solutions for patients.
Laxxon is global leader of smart drug delivery systems in the pharmaceutical industry, pioneering a new generation of advanced oral drug delivery forms with SPID®, our additive manufacturing technology platform.
For new and common pharmaceutical drugs, SPID® unlocks innovative drug delivery advancements paired with fast-tracked market access and extensive IP protection to yield disruptive opportunities in the pharmaceutical space.
Events
Laxxon has both an external pipeline and in-house Advanced Patented Generic pipeline.
03.